BLZ_BEOVU_OPHTHALMOLOGY
Drug
Novartis Pharma AG
Total Payments
$350,373
Transactions
68
Doctors
19
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $350,373 | 68 | 19 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $253,185 | 35 | 72.3% |
| Unspecified | $97,095 | 32 | 27.7% |
| Food and Beverage | $92.23 | 1 | 0.0% |
Payments by Type
General
$253,277
36 transactions
Research
$97,095
32 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Publication support research related | Novartis Pharma AG | $97,095 | 14 |
Top Doctors Receiving Payments for BLZ_BEOVU_OPHTHALMOLOGY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Ophthalmology | Reno, NV | $47,197 | 5 |
| , MD | Ophthalmology | Cleveland, OH | $40,542 | 8 |
| , M.D | Ophthalmology | Phoenix, AZ | $40,278 | 5 |
| , M.D | Ophthalmology | Houston, TX | $33,056 | 5 |
| , MD | Ophthalmology | Royal Oak, MI | $30,369 | 4 |
| , MD, PHD | Retina Specialist | Houston, TX | $29,574 | 3 |
| Jeffrey Heier | Ophthalmology | Boston, MA | $27,663 | 8 |
| , MD | Ophthalmology | Miami, FL | $17,966 | 4 |
| , M.D | Ophthalmology | Portland, OR | $16,857 | 5 |
| , MD, MPH | Rheumatology | Radnor, PA | $15,616 | 3 |
| , MD | Ophthalmology | Pasadena, CA | $10,763 | 2 |
| , M.D | Ophthalmology | Durham, NC | $9,514 | 3 |
| , MD | Ophthalmology | Cleveland, OH | $9,514 | 3 |
| , MD | Ophthalmology | Cleveland, OH | $6,929 | 2 |
| , MD | Ophthalmology | Plymouth Meeting, PA | $6,929 | 2 |
| , MD, MBA | Ophthalmology | South Miami, FL | $3,478 | 2 |
| , M.D | Ophthalmology | Boston, MA | $3,478 | 2 |
| , M.D | Ophthalmology | San Antonio, TX | $559.30 | 1 |
| , M.D | Retina Specialist | Atlanta, GA | $92.23 | 1 |
Ad
Manufacturing Companies
- Novartis Pharma AG $350,373
Product Information
- Type Drug
- Total Payments $350,373
- Total Doctors 19
- Transactions 68
About BLZ_BEOVU_OPHTHALMOLOGY
BLZ_BEOVU_OPHTHALMOLOGY is a drug associated with $350,373 in payments to 19 healthcare providers, recorded across 68 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2020 to 2020. In 2020, $350,373 was paid across 68 transactions to 19 doctors.
The most common payment nature for BLZ_BEOVU_OPHTHALMOLOGY is "Consulting Fee" ($253,185, 72.3% of total).
BLZ_BEOVU_OPHTHALMOLOGY is associated with 1 research study, including "Publication support research related" ($97,095).